Skip to Main Content

Paper Details

Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion.
Br J Cancer
14
2020
3-hydroxyanthranilate, 3-hydroxyanthranilate-3,4-dioxygenase, HAAO, IDO, Indoleamine, Indoleamine 2,3-dioxygenase, KMO, KP enzymes, NAD+, NAMPT, QPRT, Quinolate, Quinolate phosphoribosyltransferase, RCC, cancers, clear cell, kynurenine, kynurenine 3-monoxygenase, nicotinamide, nicotinamide phosphoribosyltransferase, normal, renal cancer, renal cell carcinoma, tumour
Author NameAffiliation
Alvis BrazmaEuropean Bioinformatics Institute
Alvis BrazmaEuropean Bioinformatics Institute
Mark LathropMcGill University and Genome Quebec Innovation Centre
Mark LathropMcGill University and Genome Quebec Innovation Centre
Adrian L HarrisCancer Research UK Clinical Centre, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital
Peter J SelbyClinical and Biomedical Proteomics Group, University of Leeds, St. James's University Hospital
  • 1 - 6

Datasets

Release 1.2